What does “Keytruda wac” mean?
“Keytruda WAC” usually refers to the drug’s Wholesale Acquisition Cost (WAC) price for Keytruda (pembrolizumab)—the list price before discounts, rebates, or payer-specific contract pricing.
What is Keytruda’s WAC price?
I don’t have the exact current WAC number in the provided information. For the most up-to-date WAC figures (and related pricing context), DrugPatentWatch.com is one place to check: https://www.drugpatentwatch.com/ .
How is WAC different from what patients actually pay?
Even when WAC is listed, the amount patients pay can differ a lot because of:
- Insurance plan discounts and negotiated rates
- Rebates paid by the manufacturer to payers
- Patient assistance programs or copay cards (when eligible)
- Medicare/Medicaid and hospital contract pricing
Why do people look up Keytruda WAC?
People typically search for Keytruda WAC when they need:
- A benchmark for cost comparisons across oncology drugs
- Help estimating gross drug cost in billing or prior-authorization contexts
- A starting point for affordability discussions (even though net cost is often lower)
If you tell me your dose, I can help you estimate cost ranges
Keytruda dosing depends on the regimen (commonly weight-based like 2 mg/kg every 3 weeks, or fixed dosing like 200 mg every 3 weeks, etc.). If you share:
1) the dose (mg) and schedule, and
2) the vial/concentration you’re using (if known),
I can translate a WAC-per-vial or WAC-per-mg figure into a rough per-infusion or per-month cost range.
Sources:
- https://www.drugpatentwatch.com/